Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

HBV carrying drug-resistance mutations in chronically infected treatment-naive patients

Full text
Author(s):
Show less -
Gomes-Gouvea, Michele S. [1, 2] ; Ferreira, Ariana C. [1, 2] ; Teixeira, Rosangela [3] ; Andrade, Jose R. [3] ; Ferreira, Adalgisa S. P. [4] ; Barros, Lena M. F. [4] ; Rezende, Rosamar E. F. [5] ; Santos Nastri, Ana C. S. [6, 1, 2] ; Leite, Andrea G. B. ; Piccoli, Leonora Z. ; Galvan, Josiane ; Conde, Simone R. S. S. [7] ; Soares, Manoel C. P. [8] ; Kliemann, Dimas A. [9] ; Bertolini, Dennis A. [10] ; Kunyoshi, Aline S. O. [10] ; Lyra, Andre C. [11] ; Oikawa, Marcio K. [12] ; de Araujo, Luciano V. [13] ; Carrilho, Flair J. [1, 2] ; Mendes-Correa, Maria C. J. [6] ; Rebello Pinho, Joao R. [1, 2]
Total Authors: 22
Affiliation:
Show less -
[1] Univ Sao Paulo, Dept Gastroenterol, Sch Med, Sao Paulo - Brazil
[2] Univ Sao Paulo, Sao Paulo Inst Trop Med, Lab Gastroenterol & Hepatol, Sao Paulo - Brazil
[3] Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Belo Horizonte, MG - Brazil
[4] Univ Fed Maranhao, Clin Res Ctr, Sao Luis, Maranhao - Brazil
[5] Municipal Secretary Hlth, Sao Paulo - Brazil
[6] Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo - Brazil
[7] Fundacao Santa Casa Misericordia Para, Belem, Para - Brazil
[8] Inst Evandro Chagas, Serv Hepatol, Ananindeua, Para - Brazil
[9] Hosp Nossa Senhora da Conceicao, Serv Infectol, Porto Alegre, RS - Brazil
[10] Univ Estadual Maringa, Lab Imunol Clin, Dept Anal Clin & Biomed, Maringa, Parana - Brazil
[11] Univ Fed Bahia, Dept Med, Div Gastroenterol & Hepatol, BR-41170290 Salvador, BA - Brazil
[12] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Sao Paulo - Brazil
[13] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo - Brazil
Total Affiliations: 13
Document type: Journal article
Source: ANTIVIRAL THERAPY; v. 20, n. 4, p. 387-395, 2015.
Web of Science Citations: 20
Abstract

Background: Nucleoside/nucleotide analogue (NA) treatment causes selection pressure for HBV strains carrying mutations conferring NA resistance. Drug-resistance mutations occur in the reverse transcriptase (RT) region of the HBV polymerase gene and spontaneously arise during viral replication. These mutations can also alter the hepatitis B surface (HBs) protein and in some cases reduce binding to HBs antibodies. The spread of NA-resistant HBV may impact the efficacy of antiviral treatment and hepatitis B immunization programmes. In this study, we used direct sequencing to assess the occurrence of HBV carrying known mutations that confer NA resistance in the largest cohort of treatment-naive patients with chronic hepatitis B (CHB) to date. Methods: HBV DNA samples isolated from 702 patients were sequenced and the RT region subjected to mutational analysis. Results: There was high genetic variability among the HBV samples analysed: A1 (63.7%), D3 (14.5%), A2 (3.3%), A3 (0.1%), B1 (0.1%), B2 (0.1%), C2 (0.9%), D1 (0.9%), D2 (4.6%), D4 (5.1%), D unclassified sub-genotype (0.7%), E (0.6%), F2a (4.6%), F4 (0.4%) and G (0.4%). HBV strains harbouring mutations conferring NA resistance alone or combined with compensatory mutations were identified in 1.6% (11/702) of the patients. Conclusions: HBV strains harbouring resistance mutations can comprise the major population of HBV quasispecies in treatment-naive patients. In Brazil, there is a very low frequency of untreated patients who are infected with these strains. These findings suggest that the spread and natural selection of drug-resistant HBV is an uncommon event and/or most of these strains remain unstable in the absence of NA selective pressure. (AU)

FAPESP's process: 10/51208-2 - Prevalence of primary resistance to antiviral therapy against hepatitis B in patients with chronic hepatitis B virus infection and not submitted to treatment
Grantee:Maria Cássia Jacintho Mendes Corrêa
Support Opportunities: Regular Research Grants
FAPESP's process: 10/50081-9 - Prevalence of primary resistance to antiviral therapy against hepatitis B in patients with chronic hepatitis B virus infection and not submitted to treatment
Grantee:Michele Soares Gomes Gouvêa
Support Opportunities: Scholarships in Brazil - Doctorate